Dofetilide, a New Class III Antiarrhythmic Drug Reduces Hospital Admissions for Congestive Heart Failure - Secondary Endpoints of the DIAMOND-CHF Study

1998 ◽  
Vol 31 (2) ◽  
pp. 33A ◽  
Author(s):  
L Kaber
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Antiarrhythmic Drug ◽  
Hospital Admissions ◽  
Class Iii ◽  
New Class ◽  
Class Iii Antiarrhythmic Drug ◽  
Secondary Endpoints

Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure

1996 ◽  
Vol 78 (12) ◽  
pp. 1411-1415 ◽  
Author(s):  
Stephen S. Gottlieb ◽  
Steven Singh ◽  
Mark Munger ◽  
Eric J. Eichhorn ◽  
John Ilgenfritz ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Antiarrhythmic Drug ◽  
Class Iii ◽  
Hemodynamic Effects ◽  
Class Iii Antiarrhythmic Drug
Sign in / Sign up

Export Citation Format

Share Document